Cargando…
CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling
BACKGROUND: Tumor-associated dendritic cells (TADCs) can interact with tumor cells to suppress anti-tumor T cell immunity. However, there is no information on whether and how TADCs can modulate programmed death-ligand 1 (PD-L1) expression by cancer cells. METHODS: Human peripheral blood monocytes we...
Autores principales: | Xiu, Weigang, Luo, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789583/ https://www.ncbi.nlm.nih.gov/pubmed/33407095 http://dx.doi.org/10.1186/s12865-020-00396-3 |
Ejemplares similares
-
Correction to: CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling
por: Xiu, Weigang, et al.
Publicado: (2021) -
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022) -
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020) -
Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells
por: Bronger, Holger, et al.
Publicado: (2017) -
AG490 reverses phenotypic alteration of dendritic cells by bladder cancer cells
por: Xiu, Weigang, et al.
Publicado: (2018)